<!DOCTYPE html>
<html>
<head>
<title>CV Sciences, Inc. Annual report pursuant to Section 13 and 15(d)</title>
<link href="https://ir.cvsciences.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://ir.cvsciences.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Annual report pursuant to Section 13 and 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/351">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/351">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/352">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/352">CONSOLIDATED BALANCE SHEETS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/353">CONSOLIDATED BALANCE SHEETS (Parentheticals)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/354">CONSOLIDATED STATEMENTS OF OPERATIONS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/355">CONSOLIDATED STATEMENT OF CHANGES TO STOCKHOLDERS EQUITY (DEFICIT)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/356">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/357">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/357">1. ORGANIZATION AND BUSINESS</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/358">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/359">3. INVENTORY</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/360">4. ACCRUED EXPENSES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/361">5. ACQUISITION OF ASSETS OF PHYTOSPHERE SYSTEMS, LLC</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/362">6. RELATED PARTIES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/363">7. LINE OF CREDIT - ROEN VENTURES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/364">8. STOCKHOLDERS' EQUITY (DEFICIT)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/365">9. COMMITMENTS AND CONTINGENCIES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/366">10. INCOME TAXES</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/367">11. SUBSEQUENT EVENTS</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/368">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/368">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/369">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/369">3. INVENTORY (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/370">4. ACCRUED EXPENSES (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/371">5. ACQUISITION OF ASSETS OF PHYTOSPHERE SYSTEMS, LLC (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/372">6. RELATED PARTIES (Tables)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/373">10. INCOME TAXES (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/374">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/374">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/375">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/376">3. INVENTORY (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/377">4. ACCRUED EXPENSES (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/378">5. ACQUISITION OF ASSETS OF PHYTOSPHERE SYSTEMS, LLC (Details-Allocation of purchase price)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/379">5. ACQUISITION OF ASSETS OF PHYTOSPHERE SYSTEMS, LLC (Details-Intangible assets)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/380">5. ACQUISITION OF ASSETS (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/381">6. RELATED PARTIES (Details)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/382">7. LINE OF CREDIT (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/383">8. STOCKHOLDERS' EQUITY/DEFICIT (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/384">9. COMMITMENTS AND CONTINGENCIES (Details Narrative)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/385">10. INCOME TAXES (Details-Deferred income taxes)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/386">10. INCOME TAXES (Details-Income tax provision)</a></li>
                                                            <li><a href="https://ir.cvsciences.com/all-sec-filings/xbrl_doc_only/387">10. INCOME TAXES (Details Narrative)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>6. RELATED PARTIES</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>